Diversity partners
Black Pharma partnerships are yearly commitments focused on industry-wide change. Becoming our diversity partner brings us one step closer to achieving our mission of promoting diversity and inclusivity within the pharmaceutical industry. Our partners are crucial in our mission to create access and enable success for Black professionals in the field. Through collaboration and shared dedication, we can foster a culture that values diversity, equality, and inclusion, leading to meaningful transformation in the industry.
​
Introducing our esteemed partners, Catalyst and Advocate for Change. These partners generously sponsor Black Pharma's Mentoring Program and actively support transformative initiatives, empowering future talent. Catalyst, our premier partner, leads the way in fostering diversity and professional growth within the life sciences sector. Don't miss out on opportunities from our Diversity Partners on our job board, newsletters, and talent pool updates.
​
Discover how our Partner Organisations achieve Diversity & Inclusion in the workplace.
Connect with our Catalysts for Change partners at networking events, both online and in-person, and through university outreach.
Meet our Advocates for Change partners, contributing to a more inclusive future in Pharma
Pfizer
Our purpose at Pfizer is to deliver breakthroughs that change patients’ lives, both through our biopharmaceutical innovations, and by working to ensure that those medicines and therapies can be accessed quickly and effectively by those who need them. Realising our purpose takes creativity, problem-solving skills, exceptional communication and agile decision-making. These qualities are all enhanced by rich cognitive diversity within our workforce.
GSK
GSK is a fully focused biopharma company. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics, genomics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We focus on four therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
